Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-05 |
mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.13 | 8e-05 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.12 | 9e-05 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |